146 related articles for article (PubMed ID: 12222655)
1. Therapeutic efficacy of Stephania tetrandra S. Moore for treatment of neovascularization of retinal capillary (retinopathy) in diabetes--in vitro study.
Liang XC; Hagino N; Guo SS; Tsutsumi T; Kobayashi S
Phytomedicine; 2002 Jul; 9(5):377-84. PubMed ID: 12222655
[TBL] [Abstract][Full Text] [Related]
2. Effects of oral administration of Stephania tetrandra S. Moore on neovascularization of retinal and choroidal capillaries of diabetes in rats.
Tsutsumi T; Hagino N; Liang XC; Guo SS; Kobayashi S
Phytother Res; 2008 May; 22(5):591-6. PubMed ID: 18444245
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effects of tetrandrine and related synthetic compounds on angiogenesis in streptozotocin-diabetic rodents.
Kobayashi S; Kimura I; Fukuta M; Kontani H; Inaba K; Niwa M; Mita S; Kimura M
Biol Pharm Bull; 1999 Apr; 22(4):360-5. PubMed ID: 10328554
[TBL] [Abstract][Full Text] [Related]
4. Anti-hyperglycemic effect of fangchinoline isolated from Stephania tetrandra Radix in streptozotocin-diabetic mice.
Tsutsumi T; Kobayashi S; Liu YY; Kontani H
Biol Pharm Bull; 2003 Mar; 26(3):313-7. PubMed ID: 12612439
[TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth factor- and platelet-derived growth factor-angiogenesis depressed but fetal bovine serum-angiogenesis enhanced choroidal tissue cultures of streptozotocin-diabetic Wistar and GK rats.
Kimura I; Yanagita S; Kobayshi S; Fukuta M; Okabe M
Int Angiol; 2000 Mar; 19(1):26-34. PubMed ID: 10853682
[TBL] [Abstract][Full Text] [Related]
6. The plasma glucose lowering action of tetrandrine in streptozotocin-induced diabetic rats.
Chen WC; Hayakawa S; Yamamoto T; Huang LW; Liu IM; Cheng JT
J Pharm Pharmacol; 2004 May; 56(5):643-8. PubMed ID: 15142342
[TBL] [Abstract][Full Text] [Related]
7. [Inhibitive effect of tetrandrine on the proliferation of diabetes mellitus rats vascular smooth muscle cells].
Liu MH; Xie WR; Zhang Z; Cao Y; Ren MP; Xiao SH
Zhong Yao Cai; 2009 Dec; 32(12):1867-70. PubMed ID: 20432905
[TBL] [Abstract][Full Text] [Related]
8. Anti-nociceptive, anti-inflammatory and toxicological evaluation of Fang-Ji-Huang-Qi-Tang in rodents.
Lin YC; Chang CW; Wu CR
BMC Complement Altern Med; 2015 Feb; 15():10. PubMed ID: 25652206
[TBL] [Abstract][Full Text] [Related]
9. [Pharmacological Mechanisms of Boiogito and Bofutsushosan in Diabetes and Obesity Models].
Kobayashi S
Yakugaku Zasshi; 2018; 138(3):389-403. PubMed ID: 29503432
[TBL] [Abstract][Full Text] [Related]
10. Captopril ameliorates the decreased Na+,K(+)-ATPase activity in the retina of streptozotocin-induced diabetic rats.
Ottlecz A; Bensaoula T
Invest Ophthalmol Vis Sci; 1996 Jul; 37(8):1633-41. PubMed ID: 8675407
[TBL] [Abstract][Full Text] [Related]
11. Combined effects of fangchinoline from Stephania tetrandra Radix and formononetin and calycosin from Astragalus membranaceus Radix on hyperglycemia and hypoinsulinemia in streptozotocin-diabetic mice.
Ma W; Nomura M; Takahashi-Nishioka T; Kobayashi S
Biol Pharm Bull; 2007 Nov; 30(11):2079-83. PubMed ID: 17978479
[TBL] [Abstract][Full Text] [Related]
12. Overproduction of N(epsilon)-(carboxymethyl)lysine-induced neovascularization in cultured choroidal explant of streptozotocin-diabetic rat.
Kobayashi S; Suzuki M; Tsuneki H; Nagai R; Horiuchi S; Hagino N
Biol Pharm Bull; 2004 Oct; 27(10):1565-71. PubMed ID: 15467196
[TBL] [Abstract][Full Text] [Related]
13. Endothelial F-actin cytoskeleton in the retinal vasculature of normal and diabetic rats.
Yu PK; Yu DY; Cringle SJ; Su EN
Curr Eye Res; 2005 Apr; 30(4):279-90. PubMed ID: 16020258
[TBL] [Abstract][Full Text] [Related]
14. Effect of endothelin dual receptor antagonist on VEGF levels in streptozotocin-induced diabetic rat retina.
Masuzawa K; Jesmin S; Maeda S; Zaedi S; Shimojo N; Miyauchi T; Goto K
Exp Biol Med (Maywood); 2006 Jun; 231(6):1090-4. PubMed ID: 16741055
[TBL] [Abstract][Full Text] [Related]
15. The effects of aminoguanidine on retinopathy in STZ-induced diabetic rats.
Luo D; Fan Y; Xu X
Bioorg Med Chem Lett; 2012 Jul; 22(13):4386-90. PubMed ID: 22627042
[TBL] [Abstract][Full Text] [Related]
16. Studies with an orally bioavailable alpha V integrin antagonist in animal models of ocular vasculopathy: retinal neovascularization in mice and retinal vascular permeability in diabetic rats.
Santulli RJ; Kinney WA; Ghosh S; Decorte BL; Liu L; Tuman RW; Zhou Z; Huebert N; Bursell SE; Clermont AC; Grant MB; Shaw LC; Mousa SA; Galemmo RA; Johnson DL; Maryanoff BE; Damiano BP
J Pharmacol Exp Ther; 2008 Mar; 324(3):894-901. PubMed ID: 18083913
[TBL] [Abstract][Full Text] [Related]
17. Suppressed expression of tubedown-1 in retinal neovascularization of proliferative diabetic retinopathy.
Gendron RL; Good WV; Adams LC; Paradis H
Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):3000-7. PubMed ID: 11687548
[TBL] [Abstract][Full Text] [Related]
18. Targeting the kallikrein-kinin system as a new therapeutic approach to diabetic retinopathy.
Pruneau D; Bélichard P; Sahel JA; Combal JP
Curr Opin Investig Drugs; 2010 May; 11(5):507-14. PubMed ID: 20419596
[TBL] [Abstract][Full Text] [Related]
19. Tetrandrine induces apoptosis in hepatic stellate cells.
Zhao YZ; Kim JY; Park EJ; Lee SH; Woo SW; Ko G; Sohn DH
Phytother Res; 2004 Apr; 18(4):306-9. PubMed ID: 15162366
[TBL] [Abstract][Full Text] [Related]
20. Response of capillary cell death to aminoguanidine predicts the development of retinopathy: comparison of diabetes and galactosemia.
Kern TS; Tang J; Mizutani M; Kowluru RA; Nagaraj RH; Romeo G; Podesta F; Lorenzi M
Invest Ophthalmol Vis Sci; 2000 Nov; 41(12):3972-8. PubMed ID: 11053301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
